uniQure N.V. QURE 深 沪
等待开盘 06-30 09:30:00 美东时间
47.39
-0.120
-0.25%
华盛通- 最 高49.69
- 今 开48.41
- 成交量 230.55万股
- 最 低 47.07
- 昨 收 47.51
- 总市值 29.89亿
- 52周最高 71.50
- 市盈率 静 --
- 换手率 3.66%
- 52周最低 8.73
- 委 比 -17.65%
- 总股本 6306.60万
- 历史最高 82.49
- 量 比 0.68
- 振 幅 5.51%
- 历史最低 3.73
- 每 手 1
- 风险率 14.10%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 康托·菲茨杰拉德大幅上调AMD、英特尔、迈威尔科技、美光、西部数据目标价！Applied、INIO、LFTO、Quantinuum获多家大行首予买入评级
今日重点评级关注：Evercore ISI集团：维持ProQR Therapeutics"跑赢大市"评级，目标价从5美元升至6美元；摩根士丹利：维持霍尼韦尔"标配"评级，目标价从245美元升至490美元
今天 10:14
Applied Materials To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Keybanc raised the price target for Applied Materials Inc (NASDAQ:AMAT) from $550 to $750. Keybanc analyst Ste...
06-29 21:05
What's Going On With Capricor Therapeutics Stock On Friday?
Capricor Therapeutics Inc. (NASDAQ:CAPR) stock is trading lower on Friday, down by 13%. The Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) of the U.S. Food and Drug Administration (FDA) is planning to convene an advisory committee meeting to discuss the company’s Biologics License ...
06-27 02:06
美股大行评级 | 潜在涨幅135.66%！Ocular Therapeutix获Chardan Capital升目标价至23美元，维持"买入"评级
今日重点评级关注：Chardan Capital：维持Ocular Therapeutix"买入"评级，目标价从21美元升至23美元；Guggenheim：维持Amylyx Pharmaceuticals"买入"评级，目标价从30美元升至40美元
06-26 17:42
Mizuho Maintains Outperform on uniQure, Raises Price Target to $68
Mizuho analyst Uy Ear maintains uniQure (NASDAQ:QURE) with a Outperform and raises the price target from $35 to $68.
06-26 00:17
uniQure Completes Upsized Public Equity Offering for Growth
uniQure ( ($QURE) ) has provided an update. On June 23, 2026, uniQure N.V. pric...
06-25 05:18
Backblaze, Infleqtion, Zeta Global And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Monday. Shares of Backblaze Inc (NASDAQ:BLZE) rose sharply after the company announced a five-year, $335 million multi-exabyte data storage agreement with CoreWeave Inc. (NASDAQ:CRWV). Under the agreement, Backblaze wil...
06-23 22:06
uniQure's Experimental Drug Shows Early Promise In Difficult-To-Treat Epilepsy
uniQure N.V. (NASDAQ:QURE) on Friday reported initial six-month follow-up data from the first low-dose cohort in its ongoing Phase 1/2a trial evaluating investigational gene therapy candidate AMT-260 in patients with refractory mesial temporal lobe epilepsy (MTLE). MTLE represents the most prevalent...
06-22 23:51
uniQure Announces $150 Million Proposed Public Offering
uniQure N.V. has initiated a $150 million underwritten public offering of its ordinary shares, with an option for underwriters to purchase up to an additional $22.5 million. The offering is subject to market conditions and other factors. Leerink Partners and Stifel are acting as bookrunning managers. The securities are being offered under a shelf registration statement filed with the SEC. uniQure is a leading gene therapy company advancing treatm...
06-22 20:01
美股周涨跌榜 | WOLF涨超33%，第五代SiC MOSFET技术引爆市场；西部数据涨超32%，大摩称HDD短缺或延至2028年
碳化硅行情席卷全球！WOLF涨超33%，第五代SiC MOSFET技术引爆市场；上调目标价至650美元！西部数据涨超32%，大摩称HDD短缺或延至2028年>>
06-19 10:20
